Rheumatic Diseases: An Update on Management Kent A. Huston, M.D. and K. Kwas Huston, M.D. Reach target serum uric acid levels in patients with acute gout. Initiate corticosteroid therapy in patients with temporal arteritis. Discuss the value of vertebroplasty for painful compression fractures, and sensitivity of screening assays for lupus. Distinguish primary Raynaud’s phenomenon from secondary Raynaud’s phenomenon. Select appropriate therapy for Raynaud’s phenomenon and digital ischemic ulcers.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Medication Overuse Headache: Part I Jennifer S. Kriegler, M.D. Identify medications and comorbid conditions associated with the development of MOH. Describe shared mechanisms and etiologies of headaches and other pain disorders. Restore headaches to episodic patterns by weaning key medications. Provide adjunctive treatments to help patients wean from medications associated with MOH. Prevent dangerous symptoms associated with medication toxicity and withdrawal.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Medication Overuse Headache: Part II Michael Liebenstein, Ph.D., Deborah E. Tepper, M.D. and Stewart J. Tepper, M.D. Identify psychiatric comorbidities in patients with MOH. Apply cognitive behavioral therapy and other behavioral interventions for treatment of MOH. Classify MOH and explain its physiologic basis. Describe the structural and functional changes that occur in the brain as the result of frequent migraine attacks and MOH. Discuss the role of long-term opioid use in the progression to chronic daily headache and opioid-induced hyperalgesia.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Update on Acute and Chronic Pain Joseph M. Neal, M.D. and James P. Rathmell, M.D. Describe advantages of and indications for perineural catheters. Utilize techniques to ensure proper placement of perineural catheters. Administer appropriate doses of intrathecal analgesia at appropriate times during procedures. Recognize risk factors for the development of chronic postoperative pain. Identify measures that may lower the risk for chronic postoperative pain.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Evaluating and Managing Chronic Pelvic Pain Michael S. Policar, M.D., M.P.H. Identify the most common gastrointestinal (GI), urinary tract, and gynecologic causes of CPP in women. Explain the pain generator approach for evaluating CPP in women. Recognize the interaction of pain and depression in CPP. Choose among treatment options for endometriosis. Utilize appropriate management pathways for GI, urinary tract, and gynecologic causes of CPP in women. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Pain Management Daniel J. Clauw, M.D. and Barry Eliot Cole, M.D. Appreciate pathophysiologic distinctions between acute and chronic pain. Identify factors that predispose patients to developing chronic widespread pain and central pain. Restore proper modulation of nociceptive signaling to relieve pain in patients with central pain. Explain pain-reducing mechanisms associated with different psychotropic adjuvants for pain. Provide adjuvants to relieve pain in treatment-resistant patients.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Chronic Pain Management Kevin Klauer,D.O. and Mel Pohl, M.D. Distinguish addiction from pseudoaddiction. Identify the predictors of addiction and behaviors that indicate addiction. Recognize the issues that are considered barriers to effective pain management and implement solutions. Practice strategic and conservative prescribing to avoid opioid addiction in patients with chronic pain. Discuss the effect of emotions on a patient’s perception of pain. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Migraine Robert B. Shulman, M.D. and Roger K. Cady, M.D. Identify etiologic factors shared among mood disorders, migraines, and chronic pain disorder. Distinguish patients with depressive traits due to bipolar disorder from those with unipolar depression. Explain mechanisms responsible for analgesic effects associated with multiple classes of psychiatric medications. Recognize neurologic traits that predispose patients to the development of migraine headaches. Educate patients about risk factors and protective influences that may affect the likelihood of a migraine attack.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Magraine: Communicating with Patients Mark W. Green, M.D. and Roger K. Cady, M.D. Explain potential causes and symptoms of migraines. Prevent migraine recurrence after medication use. Recognize potential causes and signs of medication overuse. Improve the efficacy of acute treatments by promoting early intervention. Recommend preventive medications and practices to reduce the frequency of headaches.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Topics in Neurology Robert T. Tenny, M.D. and Douglas Dulli, M.D. Differentiate between subarachnoid hemorrhage (SAH) and migraine and other HA disorders. Diagnose emergent neurologic conditions including arteriovenous malformation (AVM), traumatic left carotid artery dissection, and acute epidural hematoma. Evaluate the patient who presents with complaints of severe HA. Treat patients with chronic migraine. Use verapamil, prednisone, and sumatriptan to manage cluster HA.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Here is what our clients are saying about American Seminar Institute's CME seminars...
"Excellent material, I was able to earn 10 continuing education credits in Costa Rica. The opportunity to learn while enjoying a few days in paradise was fantastic." Mario,MD, Norwalk,IA
"ASI's continuing medical education program works very well for me, mostly because of the flexibility of seminar schedule. I have been a client for years and will continue to take advantage of this outstanding service" Yuri,NP,Quebec
"I'll look forward to my next seminar in Pain Management...I enjoyed the travel aspect of this program very much." Ellina,MD,Laredo,TX
